Targeting the mTOR Pathway in Hurthle Cell Carcinoma Results in Potent Antitumor Activity
Yiyu Dong(Memorial Sloan Kettering Cancer Center), Ian Ganly(Memorial Sloan Kettering Cancer Center), Rui Qu(Suzhou Municipal Hospital), Bin Xu(Memorial Sloan Kettering Cancer Center), Yongxing Gong(Memorial Sloan Kettering Cancer Center), Gouri J. Nanjangud(Memorial Sloan Kettering Cancer Center), HuiYong Zhao(Memorial Sloan Kettering Cancer Center), Eric J. Sherman, Timothy A. Chan(Cleveland Clinic), James A. Fagin(Memorial Sloan Kettering Cancer Center), Ed Reznik(Icahn School of Medicine at Mount Sinai), Vladimir Makarov(Memorial Sloan Kettering Cancer Center), Fengshen Kuo(Memorial Sloan Kettering Cancer Center), Ronald Ghossein(Memorial Sloan Kettering Cancer Center), Ömer Aras(Memorial Sloan Kettering Cancer Center)
Cited by 13